Paris - Delayed Quote EUR

Ramsay Générale de Santé SA (GDS.PA)

10.75
-0.10
(-0.92%)
At close: 5:35:15 PM GMT+2
Loading Chart for GDS.PA
  • Previous Close 10.85
  • Open 10.80
  • Bid --
  • Ask --
  • Day's Range 10.75 - 10.85
  • 52 Week Range 9.46 - 16.75
  • Volume 763
  • Avg. Volume 974
  • Market Cap (intraday) 1.186B
  • Beta (5Y Monthly) 0.18
  • PE Ratio (TTM) --
  • EPS (TTM) -0.72
  • Earnings Date Aug 28, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Dec 2, 2014
  • 1y Target Est --

Ramsay Générale de Santé SA operates healthcare facilities in France, Sweden, Norway, Denmark, and Italy. The company operates proximity care centers, and clinics and specialized hospitals; and provides primary medicine, medicine surgery obstetrics (MSO) dialysis, oncology, medical imaging, medical care, follow-up and rehabilitation care, home care and hospitalization, mental health care, and addiction treatment, telemedicine e health, elderly, emergency, maternity, nutrition, obesity and eating disorders, sanitary transport, outpatient surgery and eras, and SMR services. Ramsay Générale de Santé SA was formerly known as Générale de Santé SA and changed its name to Ramsay Générale de Santé SA in December 2015. The company was founded in 1987 and is headquartered in Paris, France. Ramsay Générale de Santé SA operates as a subsidiary of Ramsay Health Care Limited.

www.ramsaygds.fr

34,218

Full Time Employees

June 30

Fiscal Year Ends

Recent News: GDS.PA

View More

Performance Overview: GDS.PA

Trailing total returns as of 6/4/2025, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .

YTD Return

GDS.PA
13.31%
CAC 40 (^FCHI)
5.74%

1-Year Return

GDS.PA
34.05%
CAC 40 (^FCHI)
1.68%

3-Year Return

GDS.PA
56.30%
CAC 40 (^FCHI)
20.34%

5-Year Return

GDS.PA
37.50%
CAC 40 (^FCHI)
55.72%

Compare To: GDS.PA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: GDS.PA

View More

Valuation Measures

Annual
As of 6/3/2025
  • Market Cap

    1.20B

  • Enterprise Value

    4.79B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.24

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    0.93

  • Enterprise Value/EBITDA

    8.28

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.55%

  • Return on Assets (ttm)

    1.48%

  • Return on Equity (ttm)

    -5.16%

  • Revenue (ttm)

    5.14B

  • Net Income Avi to Common (ttm)

    -79.7M

  • Diluted EPS (ttm)

    -0.72

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    157.8M

  • Total Debt/Equity (mrq)

    337.92%

  • Levered Free Cash Flow (ttm)

    287.14M

Research Analysis: GDS.PA

View More

Company Insights: GDS.PA

Research Reports: GDS.PA

View More

People Also Watch